(Updated - July 7, 2022 5:30 AM EDT)

Cowen analyst Boris Peaker initiates coverage on CTI BioPharma (NASDAQ: CTIC) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE